









市場
/
株式
/
nasdaq-alny
/

Alnylam Pharmaceuticals Inc

ALNY

400.590USD

-0.100-0.02%

終値 12/26, 16:00（ET）15分遅れの株価

52.79B時価総額

1233.61直近12ヶ月PER



Alnylam Pharmaceuticals Inc

400.590

-0.100-0.02%

概要企業名金融分析

概要

企業名

金融

分析

詳細情報 Alnylam Pharmaceuticals Inc 企業名

Alnylam Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. The Company is engaged in discovering, developing, manufacturing and commercializing novel therapeutics based on ribonucleic acid interference (RNAi). Its marketed products include AMVUTTRA (vutrisiran) for the treatment of hereditary transthyretin-mediated amyloidosis (hATTR) with polyneuropathy in adults; ONPATTRO (patisiran) for the treatment of the polyneuropathy of hATTR amyloidosis in adults; GIVLAARI (givosiran) for the treatment of adults with acute hepatic porphyria; OXLUMO (lumasiran) for the treatment of primary hyperoxaluria type 1, and Leqvio (inclisiran), which is being developed and commercialized by its partner, Novartis AG, for the treatment of adults with hypercholesterolemia or mixed dyslipidemia. The Company’s clinical development programs include Cemdisiran, Fitusiran, Zilebesiran, Elebsiran, Mivelsiran and ALN-HTT02. It is developing Cemdisiran to treat complement-mediated diseases.

Alnylam Pharmaceuticals Incの企業情報



企業コードALNY

会社名Alnylam Pharmaceuticals Inc

上場日May 28, 2004

最高経営責任者「CEO」Greenstreet (Yvonne L)

従業員数2230

証券種類Ordinary Share

決算期末May 28

本社所在地675 W Kendall St

都市CAMBRIDGE

証券取引所NASDAQ OMX - NASDAQ BASIC

国United States of America

郵便番号02142-1168

電話番号16175518200

ウェブサイトhttps://www.alnylam.com/

企業コードALNY

上場日May 28, 2004

最高経営責任者「CEO」Greenstreet (Yvonne L)

Alnylam Pharmaceuticals Incの経営陣



会社名

会社名/ポジション

ポジション

株式保有

変動額

Dr. Yvonne L. Greenstreet, M.D.

Chief Executive Officer, Director

69.39K

+5.43%

Mr. Jeffrey V. (Jeff) Poulton

Chief Financial Officer, Executive Vice President

54.11K

+7.83%

Mr. Tolga Tanguler

Chief Commercial Officer

27.44K

+5.56%

Dr. Dennis A. Ausiello, M.D.

Independent Director

4.41K

Dr. Margaret A. Hamburg, M.D.

Independent Director

911.00

+569.85%

Dr. Olivier Brandicourt, M.D.

Independent Director

775.00

Mr. Peter N. Kellogg

Independent Director

775.00

Ms. Colleen F. Reitan

Independent Director

Ms. Amy W. Schulman, J.D.

Independent Chairman of the Board

Dr. Pushkal P. Garg, M.D.

Executive Vice President, Chief Research and Development Officer

詳細を見る

会社名

会社名/ポジション

ポジション

株式保有

変動額

Dr. Yvonne L. Greenstreet, M.D.

Chief Executive Officer, Director

69.39K

+5.43%

Mr. Jeffrey V. (Jeff) Poulton

Chief Financial Officer, Executive Vice President

54.11K

+7.83%

Mr. Tolga Tanguler

Chief Commercial Officer

27.44K

+5.56%

Dr. Dennis A. Ausiello, M.D.

Independent Director

4.41K

Dr. Margaret A. Hamburg, M.D.

Independent Director

911.00

+569.85%

Dr. Olivier Brandicourt, M.D.

Independent Director

775.00

収益内訳

通貨: USD更新時刻: Mon, Oct 6

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

事業別USD

会社名

収益

比率

AMVUTTRA

491.95M

63.59%

GIVLAARI

80.85M

10.45%

ONPATTRO

52.54M

6.79%

Other

50.67M

6.55%

OXLUMO

46.87M

6.06%

他の

50.81M

6.57%

地域別USD

会社名

収益

比率

United States

454.57M

58.75%

Europe

157.01M

20.29%

Net revenues from collaborations

61.50M

7.95%

Rest of World

60.63M

7.84%

Royalty revenue

39.98M

5.17%

事業別

地域別

事業別USD

会社名

収益

比率

AMVUTTRA

491.95M

63.59%

GIVLAARI

80.85M

10.45%

ONPATTRO

52.54M

6.79%

Other

50.67M

6.55%

OXLUMO

46.87M

6.06%

他の

50.81M

6.57%

株主

更新時刻: Mon, Nov 17

株主統計

種類

株主統計

比率

Capital World Investors

12.44%

Fidelity Management & Research Company LLC

12.04%

The Vanguard Group, Inc.

10.22%

Capital Research Global Investors

5.47%

BlackRock Institutional Trust Company, N.A.

4.98%

他の

54.85%

株主統計

比率

Capital World Investors

12.44%

Fidelity Management & Research Company LLC

12.04%

The Vanguard Group, Inc.

10.22%

Capital Research Global Investors

5.47%

BlackRock Institutional Trust Company, N.A.

4.98%

他の

54.85%

種類

株主統計

比率

Investment Advisor

66.37%

Investment Advisor/Hedge Fund

23.04%

Hedge Fund

3.83%

Research Firm

2.50%

Sovereign Wealth Fund

1.70%

Pension Fund

1.29%

Bank and Trust

1.20%

Corporation

1.05%

Individual Investor

0.42%

機関投資家保有株



更新時刻: Mon, Dec 8

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q4

1441

132.38M

102.07%

-8.88K

2025Q3

1468

132.43M

102.39%

+2.53M

2025Q2

1335

129.81M

101.55%

+2.82M

2025Q1

1292

127.17M

99.72%

-2.77M

2024Q4

1248

125.34M

101.87%

-989.05K

2024Q3

1210

126.51M

99.20%

+3.13M

2024Q2

1165

122.70M

94.98%

+5.27M

2024Q1

1152

117.38M

97.56%

-6.00M

2023Q4

1149

120.10M

100.10%

-712.55K

2023Q3

1103

121.13M

101.32%

-503.11K

詳細を見る

株主動向



会社名

保有株式数

比率

変動額

変動率

日付

Capital World Investors

16.81M

12.82%

+55.38K

+0.33%

Jun 30, 2025

Fidelity Management & Research Company LLC

15.05M

11.48%

+427.38K

+2.92%

Jun 30, 2025

The Vanguard Group, Inc.

13.24M

10.1%

+238.24K

+1.83%

Jun 30, 2025

Capital Research Global Investors

7.19M

5.49%

+36.93K

+0.52%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

6.53M

4.98%

-199.00K

-2.96%

Jun 30, 2025

JP Morgan Asset Management

1.79M

1.37%

-87.08K

-4.64%

Jun 30, 2025

State Street Investment Management (US)

3.17M

2.42%

-193.48K

-5.75%

Jun 30, 2025

Baillie Gifford & Co.

3.03M

2.31%

-625.72K

-17.11%

Jun 30, 2025

Geode Capital Management, L.L.C.

2.40M

1.83%

+75.94K

+3.27%

Jun 30, 2025

Dodge & Cox

3.20M

2.44%

-154.67K

-4.61%

Jun 30, 2025

詳細を見る

配当金



過去5年間の配当金総支払額は 0.00 米ドルである。

日付

配当金

権利確定日

支払日

配当落ち日

データなし

株式分割



日付

種類

比率

データなし

日付

種類

比率

データなし

よくある質問

Alnylam Pharmaceuticals Incの上位5名の株主は誰ですか？



Alnylam Pharmaceuticals Incの上位5名の株主は以下のとおりです。
Capital World Investorsは16.81M株を保有しており、これは全体の12.82%に相当します。
Fidelity Management & Research Company LLCは15.05M株を保有しており、これは全体の11.48%に相当します。
The Vanguard Group, Inc.は13.24M株を保有しており、これは全体の10.10%に相当します。
Capital Research Global Investorsは7.19M株を保有しており、これは全体の5.49%に相当します。
BlackRock Institutional Trust Company, N.A.は6.53M株を保有しており、これは全体の4.98%に相当します。